Prevalence and predictors of severe hypoglycemia in Danish children and adolescents with diabetes

Pediatric Diabetes

Volumn 16, Issue 5, 2015, Pages 354-360

  Johansen, A ^a   Kanijo, B ^a   Fredheim, S ^a,b   Olsen, B ^a   Hertz, B ^c   Lauridsen, Mh ^c   Andersen, Mlm ^a   Mortensen, Hb ^a,b   Svensson, J ^a,b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c VIBORG HOSPITAL   (Denmark)

Author keywords

BMI; DCCT; Glycemic control; HbA1c; HbA1c IDAA1c; IFCC; Pediatric; SDS; Severe hypoglycemia; SMBG; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DANISH CITIZEN; DIABETES CONTROL; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; PHYSICAL ACTIVITY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK REDUCTION; CHEMICALLY INDUCED; DIABETES MELLITUS, TYPE 1; INFANT; NEWBORN; PRESCHOOL CHILD; PROGNOSIS; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INFANT; INFANT, NEWBORN; MALE; PREVALENCE; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84936122289     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12171     Document Type: Article

References (30)

1. Bulsara MK, Holman CD, Davis EA, Jones TW. The impact of a decade of changing treatment on rates of severe hypoglycemia in a population-based cohort of children with type 1 diabetes. Diabetes Care 2004: 27: 2293-2298.
2. McCrimmon RJ, Frier BM. Hypoglycemia, the most feared complication of insulin therapy. Diabetes Metab 1994: 20: 503-512.
3. Northam EA, Anderson PJ, Jacobs R, Huges M, Warne GL, Werther GA. Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset. Diabetes Care 2001: 24: 1541-1546.
4. Northam EA, Rankins D, Cameron FJ. Therapy insight: the impact of type 1 diabetes on brain development and function. Nat Clin Pract Neurol 2006: 2: 78-86.
5. Hershey T, Lillie R, Sadler M, White NH. A prospective study of severe hypoglycemia and long-term spatial memory in children with type 1 diabetes. Pediatr Diabetes 2004: 5: 63-71.
6. Musen G, Jacobson AM, Ryan CM et al. Impact of diabetes and its treatment on cognitive function among adolescents who participated in the Diabetes Control and Complications trial. Diabetes Care 2008: 31: 1933-1938.
7. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group, Jacobson AM, Musen G, Ryan CM et al. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 2007: 356: 1842-1852.
8. Hannonen R, Komulainen J, Riikonen R et al. Academic skills in children with early-onset type 1 diabetes: the effects of diabetes-related risk factors. Dev Med Child Neurol 2012: 54: 457-463.
9. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993: 329: 977-986.
10. Svoren BM, Volkening LK, Butler DA, Moreland EC, Anderson BJ, Laffel LM. Temporal trends in the treatment of pediatric type 1 diabetes and impact on acute outcomes. J Pediatr 2007: 150: 279-285.
11. Olsen BS, Svensson J, Mortensen HB. The Danish Registry for child adolescent diabetes. The Danish Society of Child and Adolescent Diabetes. Ugeskr Laeger 2006: 168: 1210.
12. Johannesen J, Svensson J, Bergholdt R et al. Hypoglycemia, S-ACE and ACE genotypes in a Danish nationwide population of children and adolescents with type 1 diabetes. Pediatr Diabetes 2011: 12: 100-106.
13. Svensson J, Johannesen J, Mortensen HB, Nordly S. Improved metabolic outcome in a Danish diabetic pediatric population aged 0-18 yr: results from a nationwide continuous Registration. Pediatr Diabetes 2009: 10: 461-467.
14. Clarke W, Jones T, Rewers A, Dunger D, Klingensmith GJ. Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes 2009: 10 (Suppl. 12): 134-145.
15. Mortensen HB, Hougaard P, Swift P et al. New definition for the partial remission period in children and adolescents with type 1 diabetes. Diabetes Care 2009: 32: 1384-1390.
16. Rewers A, Chase HP, Mackenzie T et al. Predictors of acute complications in children with type 1 diabetes. JAMA 2002: 287: 2511-2518.
17. Danne T, Battelino T, Kordonouri O et al. A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries. Pediatr Diabetes 2005: 6: 193-198.
18. O'Connell SM, Cooper MN, Bulsara MK, Davis EA, Jones TM. Reducing rates of severe hypoglycemia in a population-based cohort of children and adolescents with type 1 diabetes over the decade 2000-2009. Diabetes Care 2011: 34: 2379-2380.
19. Danne T, Battelino T, Jarosz-Chobot P et al. Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries. Diabetologia 2008: 51: 1594-1601.
20. Danne T, Mortensen HB, Hougaard P et al. Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3, 805 children and adolescents with type 1 diabetes from the Hvidøre Study Group. Diabetes Care 2001: 24: 1342-1347.
21. Wagner VM, Grabert M, Holl RW. Severe hypoglycemia, metabolic control and diabetes management in children with type 1 diabetes in the decade after the Diabetes Control and Complications Trial - a large-scale multicentre study. Eur J Pediatr 2005: 164: 73-79.
22. Cengiz E, Xing D, Wong JC et al. Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D exchange clinic registry. Pediatr Diabetes 2013: 14: 447-454.
23. Cooperberg BA, Cryer PE. Beta-cell-mediated signaling predominates over direct alpha-cell signaling in the regulation of glucagon secretion in humans. Diabetes Care 2009: 32: 2275-2280.
24. Craig ME, Handelsman P, Donaghue KC et al. Predictors of glycaemic control and hypoglycemia in children and adolescents with type 1 diabetes from NSW and the ACT. Med J Aust 2002: 177: 235-238.
25. Davis EA, Keating B, Byrne GC, Russel M, Jones TW. Impact of improved glycaemic control on rates of hypoglycemia in insulin dependent diabetes mellitus. Arch Dis Child 1998: 78: 111-115.
26. Allen C, LeCaire T, Palta M, Daniels K, Meredith M, D'Alessio DJ. Risk factors for frequent and severe hypoglycemia in type 1 diabetes. Diabetes Care 2001: 24: 1878-1881.
27. Rosilio M, Cotton JB, Wieliczko MC et al. Factors associated with glycaemic control. A cross-sectional nationwide study in 2, 579 French children with type 1 diabetes. Diabetes Care 1998: 21: 1146-1153.
28. Levine BS, Anderson BJ, Butler DA, Antisdel JE, Brackett J, Laffel LMB. Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes. J Pediatr 2001: 139: 197-203.
29. Thomsett MJ, Shield GJ, Batch JA, Cotterill AM. How well are we doing? Metabolic control in patients with diabetes. J Paediatr Child Health 1999: 35: 479-482.
30. Nysom K, Mølgaard C, Hutchings B, Michaelsen KF. Body mass index of 0 to 45-y-old Danes: reference values and comparison with published European reference values. Int J Obes Relat Metab Disord 2001: 25: 177-184.